896 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
5 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
6 Recruiting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Condition: Primary Lung Cancer
Intervention:
7 Recruiting Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: pemetrexed disodium
8 Recruiting Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
Condition: Non Small Cell Lung Cancer
Intervention:
9 Recruiting Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 and Nab®-Paclitaxel Monotherapy as Second Line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: nab-paclitaxel IV;   Drug: CC-486
10 Recruiting Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EGF816;   Drug: INC280;   Drug: Nivolumab
11 Recruiting A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: MEK162;   Drug: Erlotinib
12 Recruiting Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer;   Platinum Responsive Malignancies
Interventions: Drug: KML-001;   Drug: Cisplatin
13 Recruiting Ipilimumab Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Ipilimumab;   Drug: Erlotinib;   Drug: Crizotinib
14 Recruiting A Study of MPDL3280A Compared With Gemcitabine + Cisplatin or Carboplatin in Patients With Stage IV Squamous Non-Small Cell Lung Cancer
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: MPDL3280A
15 Recruiting Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention:
16 Recruiting MSC2156119J With Gefitinib in Subjects With Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: MSC2156119J;   Drug: Gefitinib;   Drug: Pemetrexed;   Drug: Cisplatin
17 Unknown  Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Drug: cisplatin, vinorlebine, cetuximab;   Drug: cisplatine, etoposide, cetuximab
18 Recruiting Improving Resection Rates Among African Americans With NSCLC
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Other: Usual Care;   Other: Intervention Arm
19 Recruiting A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Radiation: Stereotactic Body Radiation Therapy plus Surgery
20 Recruiting Metformin in Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: Metformin;   Other: Placebo;   Radiation: Stereotactic body Radiotherapy (SBRT)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years